VIVUS (STU:VIU1) Ending Cash Position : €29.73 Mil (As of Mar. 2020)

View and export this data going back to . Start your Free Trial

What is VIVUS Ending Cash Position?

VIVUS's Ending Cash Position for the quarter that ended in Mar. 2020 was €29.73 Mil.

VIVUS's quarterly Ending Cash Position declined from Sep. 2019 (€36.42 Mil) to Dec. 2019 (€29.38 Mil) but then increased from Dec. 2019 (€29.38 Mil) to Mar. 2020 (€29.73 Mil).

VIVUS's annual Ending Cash Position declined from Dec. 2017 (€56.10 Mil) to Dec. 2018 (€26.73 Mil) but then increased from Dec. 2018 (€26.73 Mil) to Dec. 2019 (€29.38 Mil).

VIVUS Ending Cash Position Historical Data

The historical data trend for VIVUS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS Ending Cash Position Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Ending Cash Position

Get a 7-Day Free Trial

87.57

80.37

56.10

26.73

29.38

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Ending Cash Position	Get a 7-Day Free Trial															20.37	22.14	36.42	29.38	29.73

VIVUS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

VIVUS's Ending Cash Position for the fiscal year that ended in Dec. 2019 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	27.37	+	2.014
	=	29.38

VIVUS's Ending Cash Position for the quarter that ended in Mar. 2020 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	29.548	+	0.185
	=	29.73

VIVUS Ending Cash Position Related Terms

Thank you for viewing the detailed overview of VIVUS's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines